DTX3L increases proliferation, adhesion, and chemo-resistance of myeloma cells, by blocking caspase-3 and PARP1 expression and inhibiting apoptosis (Shen et al., 2017). The gene discussed is CASP3; the disease is plasma cell myeloma.